KOD Stock Soars After Early-Stage Data for KSI-301
In a development that would come as a major boost to KOD stock, Kodiak Sciences Inc (NASDAQ:KOD) announced impressive results from the clinical trial of one of its products. The company presented the data from ... [Read]
XLRN Stock Hits New High on Positive Trial Results of PAH Treatment
XLRN stock surged 43% on Tuesday after Acceleron Pharma Inc. (NASDAQ:XLRN) announced that its trial treatment for pulmonary arterial hypertension (PAH), sotatercept, had met its primary endpoint midway in the study. Acceleron Lifted By Trial ... [Read]
APLS Stock Hits All-Time High: APL-2’s Phase 3 Impressive Results
Positive results from late-stage clinical trials almost always prove to be a major positive for the stock of any pharmaceutical company, and that is what happened with APLS stock this morning. In a new development, ... [Read]
BLUE Stock Gains 20% in Two Weeks: Key Factors to Watch
Biotech stocks are usually tricky to invest in, and they are not for faint-hearted investors. They are a high-risk investment because the companies have no guarantee their drugs will be successful. A mistake in the ... [Read]
AMRN Stock Jumps 5% After FDA Approves Vascepa for Wider Use
AMRN stock jumped to a new decade high on Monday following FDA marketing approval for Amarin Corporation’s (NASDAQ:AMRN) drug Vascepa. Expanded Approval of Vascepa The regulator approved the drug for expanded use in preventing cardiovascular ... [Read]
SRPT Stock Surges 36% After FDA Approves Duchenne Drug
SRPT stock jumped 32% in early trading on Friday after the FDA approved the genetic medicine developed by Sarepta Therapeutics (NASDAQ:SRPT), the muscular dystrophy drug Vyondys 53. FDA Approves Vyondys 53 for Treatment of Duchenne ... [Read]
AMRN Stock Extends Rally as FDA Approves Vascepa Label Expansion
When a pharmaceutical company makes a positive announcement with regards to one of its products, then its stock almost always moves in the right direction. Something of the same nature is being hoped for with ... [Read]
RETA Stock Soars 157% in a Month: Are You Excited?
RETA stock has soared over 155% over the past month on multiple news from Reata Pharmaceuticals Inc (NASDAQ:RETA). Many pharmaceutical stocks have enjoyed significant gains this year, but there are very few stocks that have ... [Read]
BGNE Stock Soars After Amgen Invests $2.7B in BeiGene
BGNE stock is on roll after Amgen Inc. (NASDAQ:AMGN) announced that it is investing around $2.7 billion in Chinese biotech company BeiGene Ltd (NASDAQ:BGNE). The company will take a 20.5% stake in the drug developer. ... [Read]
ACAD Stock Hits Multi-Year Highs on Impressive Data
ACAD stock is the biggest biotech stock gainer in Monday’s session after ACADIA Pharmaceuticals (NASDAQ:ACAD) announced successful results in its Phase 3 clinical trial of HARMONY. Big Relief for Investors When a pharmaceutical company announces ... [Read]